βIII-tubulin expression as a predictor of docetaxel resistance in metastatic castrate-resistant prostate cancer.
Bertha E. Sanchez(Henry Ford Health System), Clara Hwang(Henry Ford Health System), Meredith Mahan(Henry Ford Health System), Evelyn Barrack(Johns Hopkins University), Nilesh Gupta(Henry Ford Health System), Prem-veer Reddy(Henry Ford Hospital)
Cited by 1
Related Papers
Androgen receptor gene mutations in human prostate cancer.
|Proceedings of the National Academy of Sciences|1992|420
Rb Loss Is Characteristic of Prostatic Small Cell Neuroendocrine Carcinoma
|Clinical Cancer Research|2013|358
Succinate dehydrogenase-deficient renal cell carcinoma: detailed characterization of 11 tumors defining a unique subtype of renal cell carcinoma
|Modern Pathology|2014|227
ERG gene rearrangements are common in prostatic small cell carcinomas
|Modern Pathology|2011|219